Skip to main content
HR 172 117th Congress House Sports and Recreation Alternative dispute resolution, mediation, arbitration Athletes Child health Congressional oversight Criminal investigation, prosecution, interrogation Drug safety, medical device, and laboratory regulation Drug, alcohol, tobacco use Due process and equal protection International law and treaties International organizations and cooperation Medical tests and diagnostic methods Olympic games

United States Anti-Doping Agency Reauthorization Act of 2021

Introduced: January 4, 2021 Introduced by: Thompson, Mike Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 12 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 15, 2021
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Apr 14, 2021
Motion to reconsider laid on the table Agreed to without objection.
Apr 14, 2021
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)
Apr 14, 2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99).(text: CR H1748)
Apr 14, 2021
Considered as unfinished business. (consideration: CR H1781-1782)
Apr 14, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Apr 14, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 172.
Apr 14, 2021
Considered under suspension of the rules. (consideration: CR H1748-1750)
Apr 14, 2021
Mr. Pallone moved to suspend the rules and pass the bill.
Feb 2, 2021
Referred to the Subcommittee on Health.
Jan 4, 2021
Referred to the House Committee on Energy and Commerce.
Jan 4, 2021
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Apr 14, 2021 House · vote #99 On Motion to Suspend the Rules and Pass Passed 381–37 See who voted →
 Plain-English summary Congressional Research Service

United States Anti-Doping Agency Reauthorization Act of 2021

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.

The bill adds requirements that USADA

  • be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and
  • promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.

The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.

The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

What's happening now April 15, 2021

Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

 Committees of jurisdiction 3
 Cosponsors 1
All 1 Democratic 1